In the group of pretreated AMD subjects (patients who had not undergone any anti-VEGF treatment for three months before being included in the study but had received ranibizumab injections before), the mean ETDRS score increased from 66.4 to 69.7. The gene discussed is VEGFA; the disease is age-related macular degeneration.